-
Something wrong with this record ?
Minimally invasive fibrin sealant application in pilonidal sinus: a comparative study
M. Saedon, A. Chin, M. Alfa-Wali, C. K. Khoo, A. Varma
Language English Country Czech Republic
Document type Journal Article
NLK
Directory of Open Access Journals
from 2012
Medline Complete (EBSCOhost)
from 2012-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2013
- MeSH
- Adult MeSH
- Fibrin Tissue Adhesive * therapeutic use MeSH
- Humans MeSH
- Neoplasm Recurrence, Local MeSH
- Pilonidal Sinus * surgery MeSH
- Recurrence MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
The aim of this study was to compare the filling of the pilonidal sinus tract with fibrin sealant (FS) against tract excision and primary closure (PC) as the primary procedure. Details of all patients who underwent treatment for a symptomatic first episode of pilonidal sinus disease between January 2011 and December 2015 were prospectively recorded in a custom database. Patients underwent PC (n=17) or FS (n=17) according to patient preference. Prior surgical treatment and ongoing infection precluded entry. Patients were treated with antibiotics if presenting with infection. Outcomes measured were recurrence, further procedures, outpatient attendances and length of follow-up to resolution. 34 consecutive patients [FS vs. PC: male n=15 vs. 12 p=0.398; mean age 29 (SEM 12) vs. 30 (SEM 15) p=0.849] were included. Treated preoperative infections were similar FS (n=5) vs. PC (n=12) (p=0.038, chi-squared test). FS cohort had more sinuses FS median (range) 2 (1-4) vs. PC 1 (1-3) (p=0.046). Postoperative outcomes: recurrence rate FS (n=5) vs. PC (n=4) (p=0.629); infection rate FS (n=1) vs. PC (n=8) (p=0.045); total number of operations required FS 1 (1-2) vs. PC 1 (1-4) (p=0.19); total number of outpatient attendance FS 2 (1-7) vs. PC 3 (1-16) (p=0.629); follow-up FS 129 days ± 33 vs. PC 136 ± 51 (p=0.914). Fibrin sealant is not inferior to excision followed by primary closure.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19015109
- 003
- CZ-PrNML
- 005
- 20190430145018.0
- 007
- ta
- 008
- 190423s2018 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.14712/23362936.2018.10 $2 doi
- 035 __
- $a (PubMed)30414361
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Saedon, Mahmud $u Grantham and District Hospital, Grantham, United Kingdom
- 245 10
- $a Minimally invasive fibrin sealant application in pilonidal sinus: a comparative study / $c M. Saedon, A. Chin, M. Alfa-Wali, C. K. Khoo, A. Varma
- 520 9_
- $a The aim of this study was to compare the filling of the pilonidal sinus tract with fibrin sealant (FS) against tract excision and primary closure (PC) as the primary procedure. Details of all patients who underwent treatment for a symptomatic first episode of pilonidal sinus disease between January 2011 and December 2015 were prospectively recorded in a custom database. Patients underwent PC (n=17) or FS (n=17) according to patient preference. Prior surgical treatment and ongoing infection precluded entry. Patients were treated with antibiotics if presenting with infection. Outcomes measured were recurrence, further procedures, outpatient attendances and length of follow-up to resolution. 34 consecutive patients [FS vs. PC: male n=15 vs. 12 p=0.398; mean age 29 (SEM 12) vs. 30 (SEM 15) p=0.849] were included. Treated preoperative infections were similar FS (n=5) vs. PC (n=12) (p=0.038, chi-squared test). FS cohort had more sinuses FS median (range) 2 (1-4) vs. PC 1 (1-3) (p=0.046). Postoperative outcomes: recurrence rate FS (n=5) vs. PC (n=4) (p=0.629); infection rate FS (n=1) vs. PC (n=8) (p=0.045); total number of operations required FS 1 (1-2) vs. PC 1 (1-4) (p=0.19); total number of outpatient attendance FS 2 (1-7) vs. PC 3 (1-16) (p=0.629); follow-up FS 129 days ± 33 vs. PC 136 ± 51 (p=0.914). Fibrin sealant is not inferior to excision followed by primary closure.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a fibrinová tkáňová adheziva $x terapeutické užití $7 D015718
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lokální recidiva nádoru $7 D009364
- 650 12
- $a pilonidální sinus $x chirurgie $7 D010864
- 650 _2
- $a recidiva $7 D012008
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Chin, Andrew $u Grantham and District Hospital, Grantham, United Kingdom
- 700 1_
- $a Alfa-Wali, Maryam $u Royal London Hospital, London, United Kingdom
- 700 1_
- $a Khoo, Chun Kheng $u Grantham and District Hospital, Grantham, United Kingdom
- 700 1_
- $a Varma, Aarti $u Grantham and District Hospital, Grantham, United Kingdom
- 773 0_
- $w MED00013414 $t Prague medical report $x 1214-6994 $g Roč. 119, č. 2-3 (2018), s. 107-112
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30414361 $y Pubmed
- 856 41
- $u https://pmr.lf1.cuni.cz/media/pdf/pmr_2018119020107.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 7 $c 1071 $y 4 $z 0
- 990 __
- $a 20190423 $b ABA008
- 991 __
- $a 20190430132256 $b ABA008
- 999 __
- $a ok $b bmc $g 1399654 $s 1053508
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 119 $c 2-3 $d 107-112 $i 1214-6994 $m Prague Medical Report $n Prague Med. Rep. $x MED00013414
- LZP __
- $b NLK118 $a Pubmed-20190423